收藏 分享
收录年代
序号 标题 作者 起始页 操作
1 How is your carbon footprint? McCann, Shaun 1,053
2 Hematopoietic stem cell transplantation and cellular therapies for autoimmune diseases: overview and future considerations from the Autoimmune Diseases Working Party (ADWP) of the European Society for Blood and Marrow Transplantation (EBMT) Alexander, Tobias, Greco... 1,055
3 Comparative analysis of Decitabine intensified BUCY2 and BUCY2 conditioning regimen for high-risk MDS patients undergoing allogeneic hematopoietic stem cell transplantation Zhang, Ran, Lu... 1,063
4 Allogeneic hematopoietic cell transplantation in patients with therapy-related myeloid neoplasm after breast cancer: a study of the Chronic Malignancies Working Party of the EBMT Nabergoj, Mitja, Mauff... 1,072
5 Impact of CDC warning on co-prescribing of opioids and benzodiazepines in older allogeneic hematopoietic cell transplant recipients Bhargava, Divya, Drilling... 1,079
6 Infusion of haploidentical HSCs combined with allogenic MSCs for the treatment of ALL patients Zhu, Ling, Xue... 1,086
7 Low-dose unfractionated heparin prophylaxis is a safe strategy for the prevention of hepatic sinusoidal obstruction syndrome after myeloablative adult allogenic stem cell transplant Sola, Maria, Bhatt... 1,095
8 CD34+-selected hematopoietic stem cell transplant conditioned with a myeloablative regimen in patients with advanced myelofibrosis Sauter, Craig S., Perales... 1,101
9 Health-related quality of life in pediatric patients with beta-thalassemia major after hematopoietic stem cell transplantation Zhai, Lu, Liang... 1,108
10 Impact of conditioning regimen intensity on outcomes of second allogeneic hematopoietic cell transplantation for secondary acute myelogenous leukemia Nagler, Arnon, Peczynski... 1,116